- Case report
- Open Access
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection
BMC Infectious Diseases volume 16, Article number: 230 (2016)
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a clinico-radiological syndrome characterized by transient mild symptoms of encephalopathy and a reversible lesion in the splenium of the corpus callosum on magnetic resonance imaging (MRI). It is often triggered by infection. The common pathogens of MERS are viruses, especially influenza virus. However, Mycoplasma pneumoniae (M.pneumoniae) are relatively rare pathogens for MERS.
Here we report two paediatric cases of M.pneumoniae infection-induced MERS. The diagnosis of M.pneumoniae infection was established based on polymerase chain reaction (PCR) and specific serum antibodies (IgM). Both of the two patients presented with mild encephalopathy manifestations and recovered completely within a few days. The initial MRI showed a lesion in the central portion of the splenium of the corpus callosum, which completely resolved on the seventh and eighth day after admission for case 1 and case 2. Lumbar puncture was performed in both patients, which revealed no pleocytosis. In case 1, the patient had hyponatremia, peripheral facial nerve paralysis, and rash. To the best of our knowledge, it is the first MERS case associated with peripheral nerve damage. In case 2, interleukin-6(IL-6) was moderately increased in the cerebrospinal fluid (CSF). It suggested that IL-6 may play a role in the pathogenesis of M.pneumoniae-induced MERS.
Our study enriches the available information on the pathogens of MERS and provides valuable data for better understanding of this syndrome.
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a clinico-radiological syndrome, which was first reported by Tada et al. in 2004  and further enriched by Takanashi et al . The most common clinical feature is a neurological dysfunction, including delirious behavior, consciousness disturbance, and seizures, all of which recover completely within 1 month . Typical magnetic resonance imaging (MRI) findings of MERS include damage to the splenium of the corpus callosum in the acute phase, and sometimes damage spread to the whole corpus callosum and adjacent white matter. The corpus callosum connects the two cerebral hemispheres, and the splenium is located in the corpus callosum backend. The high-signal lesions are typically symmetrical and notable without enhancement on T2- and diffusion-weighted sequences, especially on the diffusion-weighted sequence. Lesions on the MRI images often disappear in 1 week or a few weeks [1, 2].
MERS may affect adults and children. Its pathogenesis is not clear and often triggered by infection. The most common pathogen is influenza virus A and B, and others include rotavirus, measles virus, adenovirus, Streptococcus, and Escherichia coli . Mycoplasma pneumoniae (M.pneumoniae) infection-related MERS is rare [4–6], and MERS has not been previously mentioned in the literature among M.pneumoniae-related central nervous system (CNS) dysfunction . Here, we report 2 cases of M.pneumoniae infection-induced MERS to enrich the available information on the pathogens of MERS and the pathogenic spectrum of M.pneumoniae-related CNS dysfunction.
A 9-year-old male patient was admitted to the hospital because of fever for 2 days, and headache, vomiting, mouth drooping on the right side, and rash for 1 day. Physical examination showed a body temperature of 38.7 °C and otherwise normal vital signs. Red maculopapular rashes that faded under pressure were scattered all over the body. Neurological examination showed poor mental status and obvious lethargy. Cranial nerve examination revealed mouth drooping on the right side, incomplete eyelid closure and shallow nasolabial sulcus on the left side because of the left peripheral facial paralysis, which is known to be associated with M.pneumoniae infection. Meningeal irritation and bilateral Babinski’s signs were negative.
Peripheral blood analysis showed a leukocyte count of 4500/μL, hemoglobin 12.1 g/dL, platelet count 251,000/μL, and C-reactive protein 16 mg/L(normal range, 0.0–8.0 mg/L). His serum sodium was 127 mmol/L(normal range, 135–145 mmol/L). The pharyngeal swab sample detected M.pneumoniae DNA copies 1.1 × 104 per mL by using polymerase chain reaction (PCR). Specific serum M. pneumoniae antibodies (IgM) were positive at a titre of 1.71 on the sixth day of the disease (ELISA, normal value:< 1.1). Specific serum IgM antibodies (ELISA) against chlamydia, herpes simplex virus, varicella zoster, cytomegalovirus, Epstein-Barr virus, rubella, toxoplasma, influenza A and B, measles virus, adenovirus, and Japanese encephalitis virus infections were negative. The PCR was negative for influenza A and B in pharyngeal swab. Rotavirus antigen was not detected in his stool specimen. Other blood biochemical tests and urine analysis were normal. The cytokines were not assessed in the serum and cerebrospinal fluid (CSF). CSF was normal with 2 white cell/mL, 20.1 mg/dL protein, and 70.6 mg/dL glucose. M. pneumoniae and herpes simplex virus PCR analyses in CSF were negative. The electroencephalogram (EEG) revealed diffuse slow waves. Cranial MRI showed a focal high-signal lesion in the splenium of the corpus callosum on diffusion-weighted and T2-weighted images on the day of admission (Fig. 1a, b).
After admission, treatment included acyclovir (10 mg/kg 8 hourly) for herpes viruses infection before the M.pneumoniae infection was confirmed, mannitol (5 ml/kg 8 hourly) for reduction of intracranial pressure, dexamethasone(0.4 mg/kg/d) for reduction of facial nerve swelling, and methycobal (1000 mg/d) for facial nerve paralysis. After M.pneumoniae infection was confirmed, azithromycin (10 mg/kg/day) was administered for 5 days. The symptoms improved significantly. Two days after admission, the patient no longer had lethargy, headache, vomiting, and had normal body temperature. Four days after admission, the patient showed improvement in mouth drooping on the right side, incomplete eyelid closure, and stabilization of the rash. Seven days after admission, his serum sodium was 135 mmol/L and his EEG was normal. Re-examination of the cranial MRI, he had normal MRI signals in the corpus callosum (Fig. 1c, d). Ten days after admission, the patient was discharged with excellent mental status, no obvious mouth drooping, substantially restored ability to close the left eyelid, and no rash.
A 12-year-old male patient was admitted to the hospital because of fever for 6 days, and headache, dizziness, vomiting, and cough for 4 days. Physical examination showed a body temperature of 38 °C and otherwise normal vital signs. The breath sound in the right lower lung was low. Neurological examination showed poor mental status and obvious lethargy. Cranial nerve examination did not reveal abnormal findings. Meningeal irritation and bilateral Babinski’s signs were negative.
Peripheral blood analysis showed a leukocyte count of 8100/μL, hemoglobin 13.0 g/dL, platelet count 253,000/μL, and C-reactive protein 14 mg/L. His serum sodium was 139 mmol/L. The sputum sample detected M.pneumoniae DNA copies 1.25 × 104 per mL through the PCR. Specific serum M. pneumoniae antibodies (IgM) were positive at a titre of 2.11 on the seventh day of the disease (ELISA, normal value:< 1.1). The above viruses IgM antibodies were also negative. The PCR was negative for influenza A and B in sputum sample and rotavirus antigen was also not detected in his stool specimen. Blood biochemical tests did not show abnormal findings. Cytokines levels were examined in serum and CSF. The results revealed the concentration of interleukin-6(IL-6) was normal in serum and moderately increased in the CSF. The concentration of IL-6 in the serum and CSF was 9 pg/mL and 101 pg/mL(ELISA, normal range < 10 pg/mL), respectively. The levels of other cytokines were normal in serum and CSF. The CSF examination showed no abnormalities. M. pneumoniae and herpes simplex virus PCR analyses in CSF were also negative. X-ray suggested right lower lobe pneumonia. The EEG also demonstrated global diffuse slow waves. Cranial MRI showed a focal high-signal lesion in the splenium of the corpus callosum on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images on the day of admission (Fig. 2a, b).
After admission, acyclovir (10 mg/kg 8 hourly) was used for herpes viruses infection. After M. pneumoniae infection was confirmed, azithromycin (10 mg/kg/day) was administered for 5 days. Mannitol (5 ml/kg 8 hourly) was used to decrease the intracranial pressure. Two days after admission, the patient showed an improvement in disturbed consciousness and reduced headaches, dizziness, and vomiting. Three days after admission, the patient had normal mental status, normal body temperature, and apparent cough relief. Eight days after admission, the patient was discharged with excellent mental status, no obvious cough, normal EEG findings, and no abnormal MRI signals in the corpus callosum (Fig. 2c, d).
MERS is characterized by acute mild symptoms of encephalopathy occurring during an acute inflammatory disease process. Brain MRIs show characteristic changes in the corpus callosum, and recovery occurs without special treatment. MERS is divided into type 1 (damage limited to the splenium of the corpus callosum on MR images) and type 2 (damage spread to the entire corpus callosum or adjacent white matter or both) . Type 1 MERS is more common.
Most currently reported MERS cases are concentrated in East Asia, especially in Japan, and in children [2, 9]. The most common pathogens are viruses (rotavirus, measles virus, adenovirus, and especially influenza virus) and a few bacteria (Table 1)[3, 9]. However, cases of M.pneumoniae infection-induced MERS are relatively rare. M.pneumoniae is a common pathogen of respiratory tract infection in children. Therefore, studying pathogens including M.pneumoniae can help us understand the etiology and pathogenesis of MERS. CNS disorders such as encephalitis, meningitis, cerebellitis, and myelitis are common extrapulmonary manifestations of M.pneumoniae infection, which can also damage the skin and mucosa. However, MERS has not been reported among M.pneumoniae-related CNS dysfunction. In the present study, both patients had clinical and imaging manifestations of MERS after M.pneumoniae infection, and according to MRI findings, were diagnosed as having type 1 MERS. Notebaert et al.  and Zhao et al.  each reported 1 case of M.pneumoniae infection-induced type 2 MERS, respectively, and Shibuya et al.  reported 1 adult case of M.pneumoniae infection-induced type 1 MERS. However, little has been reported about child cases of M.pneumoniae infection-induced type 1 MERS. In the present study, case 1 had symptoms of not only MERS but also peripheral facial nerve paralysis and rash. To the best of our knowledge, it is the first MERS case associated with peripheral nerve damage, although the peripheral facial paralysis is known to be associated with M.pneumoniae infection . This case shows that M.pneumoniae infection can cause damage to multiple systems and enriches the spectrum of clinical manifestations of MERS.
The pathogenesis of MERS remains unclear. Possible mechanisms include transient intramyelinic edema, interstitial axonal edema, and inflammatory infiltration due to a myelin specific neurotoxin released by the pathogen [1, 2, 11], thus resulting in the transiently reduced diffusion seen on MRI. Takanashi et al.  suggested that the process of MERS may involve hyponatremia. Hyponatremia reduces the intracellular osmotic pressure in the splenium of the corpus callosum to facilitate free water entry, leading to transient cerebral edema. In the present study, the early serum sodium level was 127 mmol/L in case 1 and normal in case 2. In addition, the serum sodium level in the case of type 2 MERS reported by Zhao et al.  was also within the normal range. It suggests the possible but not essential involvement of hyponatremia in the pathogenesis of M.pneumoniae-induced MERS. Some other investigators have suggested the involvement of cytokines. Mori et al.  found that the CSF level of IL-6 increased significantly in a child with rotavirus-related MERS, while serum level of interleukin-1β, IL-6, interleukin-8, and tumor necrosis factor-α also increased in MERS children with Kawasaki disease , suggesting that the pathogenesis of MERS may involve the activation of the immune system. In the present study, IL-6 was moderately increased in the CSF of patient 2, but was not assessed in the serum and CSF of patient 1. Accordingly, we speculate that IL-6 may be involved in M.pneumoniae-induced MERS, but verification of more cases is needed.
MERS, especially type 2 MERS, should be distinguished from other leukoencephalopathies such as acute disseminated encephalomyelitis (ADEM), reversible posterior leukoencephalopathy syndrome (RPLS), and hereditary leukoencephalopathy. In particular, ADEM has clinical manifestations similar to those of MERS during its early stage. However, their MRI findings are different. In ADEM, lesions are distributed asymmetrically and most obvious in the T2-weighted sequence; diffusion is not restricted; enhancement can be observed after use of contrast agents, and the corpus callosum is less likely involved. On the contrary, in MERS, the corpus callosum is often involved symmetrically; the white matter damage is also symmetrical, and diffusion is significantly restricted without enhancement . Through differential diagnosis, MERS can be diagnosed in a timely and precise manner to avoid overtreatment.
In conclusion, we reported two paediatric cases of type I MERS with coinciding M. pneumoniae detection. Our study enriches the available information on the pathogens of MERS and provides valuable data for better understanding of this syndrome. Recognizing this syndrome early in children can avoid overtreatment and provide reassurance about the good prognosis of the disease.
ADEM, acute disseminated encephalomyelitis; CNS, central nervous system; CSF, cerebrospinal fluid; EEG, electroencephalogram; IL-6, interleukin-6; MERS, clinically mild encephalitis/encephalopathy with a reversible splenial lesion; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; RPLS, reversible posterior leukoencephalopathy syndrome.
Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–8.
Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009;31:521–8.
Okamoto T, Sato Y, Yamazaki T, Hayashi A. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection. Eur J Pediatr. 2014;173:533–6.
Shibuya H, Osamura K, Hara K, Hisada T. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion due to Mycoplasma pneumoniae infection. Intern Med. 2012;51:1647–8.
Notebaert A, Willems J, Coucke L, Van Coster R, Verhelst H. Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis. Pediatr Neurol. 2013;48:135–8.
Zhao L, Wu Y, Guo M, Xiao J, Jiang Y. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in a child andliterature review. Zhonghua Er Ke Za Zhi. 2014;52:218–22.
Yis U, Kurul SH, Cakmakçi H, Dirik E. Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr. 2008;167:973–8.
Takanashi J, Imamura A, Hayakawa F, Terada H. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci. 2010;292:24–7.
Hoshino A, Saitoh M, Oka A, Okumura A, Kubota M, Saito Y, et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev. 2012;34:337–43.
Völter C, Helms J, Weissbrich B, Rieckmann P, Abele-Horn M. Frequent detection of Mycoplasma pneumoniae in Bell’s palsy. Eur Arch Otorhinolaryngol. 2004;261:400–4.
Ka A, Britton P, Troedson C, Webster R, Procopis P, Ging J, et al. Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. Eur J Paediatr Neurol. 2015;19:377–82.
Takanashi J, Tada H, Maeda M, Suzuki M, Terada H, Barkovich AJ. Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain Dev. 2009;31:217–20.
Mori T, Morii M, Kuroiwa Y, Hotsubo T, Fuse S, Tsutsumi H. Rotavirus encephalitis and cerebellitis with reversible magnetic resonance signal changes. Pediatr Int. 2011;53:252–5.
Takanashi J, Shirai K, Sugawara Y, Okamoto Y, Obonai T, Terada H. Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci. 2012;315:167–9.
Bulakbasi N, Kocaoglu M, Tayfun C, Ucoz T. Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol. 2006;27:1983–6.
Ganapathy S, Ey EH, Wolfson BJ, Khan N. Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. Pediatr Radiol. 2008;38:1243–5.
The authors would like to thank Mrs Yan Cheng for excellent technical support.
Availability of data and materials
All the data supporting our findings are contained within this article.
Gao F, Xia ZZ and Jiang PF contributed to the study design, and Yuan ZF drafted the manuscript. Yu YL, Xu L and Mao SS helped to draft the manuscript. Shen J helped to draft the manuscript and helped to treat the patients. All authors read and approved the final manuscript.
The authors declare no competing interests.
Both patients’ parents provided written informed consent for the publication of the case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
The study was conducted in accordance with Declaration of Helsinki and ethically approved by the Ethics Committee of the Children’s Hospital of Zhejiang University School of Medicine.
This study was supported from the Grants of the Natural Science Fundation of Zhejiang Province (LY14H090007), the Zhejiang Health Bureau Fund (2014KYA126) and the Population and Family planning fund of Zhejiang Province (2014kyb335).
About this article
Cite this article
Yuan, Z., Shen, J., Mao, S. et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection. BMC Infect Dis 16, 230 (2016). https://0-doi-org.brum.beds.ac.uk/10.1186/s12879-016-1556-5
- Mycoplasma pneumoniae
- Corpus callosum